$2.15
-0.07-3.15%
At close: -
$2.34
0.198.84%
After Hours: Feb 20, 6:20 PM EDT
Oramed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Oramed Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-0.48 | $-0.07 | -585.7 % |
Q2 | 2024-08-16 | $0.22 | $0.01 | 2100.0 % |
Q1 | 2024-05-09 | $0.04 | $0.02 | 100.0 % |
Q4 | 2024-03-06 | $0.33 | $-0.12 | 375.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2024-08-16 | $0 | $250.00K | -100.0 % |
Q3 | 2023-11-09 | $0 | $700.00K | -100.0 % |
Q2 | 2023-08-10 | $674.00K | $700.00K | -3.71 % |
Q1 | 2023-05-11 | $666.00K | $750.00K | -11.2 % |
Oramed Pharmaceuticals (ORMP) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.48, which missed the estimate of $-0.07.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.